Enovis Corporation ENOV 深 沪
等待开盘 04-01 09:30:00 美东时间
22.75
+1.060
+4.89%
华盛通- 最 高22.87
- 今 开22.14
- 成交量 83.86万股
- 最 低 21.59
- 昨 收 21.69
- 总市值 13.02亿
- 52周最高 37.85
- 市盈率 静 --
- 换手率 1.46%
- 52周最低 21.00
- 委 比 1.96%
- 总股本 5724.51万
- 历史最高 176.11
- 量 比 1.30
- 振 幅 5.90%
- 历史最低 -13.31
- 每 手 1
- 风险率 4.03%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Enovis Chief Administrative Officer Oliver Engert acquires USD 23,740 in common shares
Enovis Chief Administrative Officer Oliver Engert acquires USD 23,740 in common shares Oliver Engert, Chief Administrative Officer of Enovis, reported the acquisition of 1,000 common shares at a price of USD 23.74 per share. Following the transaction, Engert beneficially owned 48,640 common shares.
03-17 09:00
美股大行评级 | 最高300美元！大摩、小摩、花旗纷纷上调英伟达目标价；赛富时、C3.ai、Snowflake、Trade Desk等遭数十家机构下调目标价
今日重点评级关注：HC Wainwright & Co.：维持NovoCure"买入"评级，目标价从47美元升至49美元；Citizens：维持Ironwood医药"跑赢大市"评级，目标价从8美元升至10美元
02-27 11:07
财报速睇 | Enovis Corporation 2025财年年度营收22.48亿美元，同比增长6.7%；归母净利润亏损11.84亿美元，同比亏损扩大43.5%
华盛资讯2月27日讯，Enovis Corporation公布2025财年年度业绩，公司年度营收22.48亿美元，同比增长6.7%，归母净利润亏损11.84亿美元，同比亏损扩大43.5%。
02-27 09:50
BTIG Maintains Buy on Enovis, Raises Price Target to $43
BTIG analyst Ryan Zimmerman maintains Enovis (NYSE:ENOV) with a Buy and raises the price target from $41 to $43.
02-27 02:43
Enovis shares are trading higher after the company reported better-than-expected Q4 adjusted EPS results and issued FY26 adjusted EPS guidance above estimates.
Enovis shares are trading higher after the company reported better-than-expecte...
02-26 23:22
财报速睇 | Enovis Corporation 2025财年Q4营收5.76亿美元，同比增长2.6%；归母净利润亏损5.21亿美元，同比亏损缩窄26.0%
华盛资讯2月26日讯，Enovis Corporation公布2025财年Q4业绩，公司Q4营收5.76亿美元，同比增长2.6%，归母净利润亏损5.21亿美元，同比亏损缩窄26.0%。
02-26 20:05
Earnings Scheduled For February 26, 2026
Companies Reporting Before The Bell • Enovis (NYSE:ENOV) is estimated to report...
02-26 19:11
Enovis Sees FY2026 Adj EPS $3.52-$3.73 vs $3.43 Est; Sees Sales $2.310B-$2.370B vs $2.362B Est
Enovis (NYSE:ENOV) is looking for FY2026 Adj EPS of $3.52-$3.73 vs $3.43 analyst estimate. sees sales of $2.310 billion-$2.370 billion vs $2.362 billion analyst estimate.
02-26 19:11
Enovis Q4 net loss from continuing operations hits USD 519 million as net sales rise 3% to USD 576 million
Enovis Q4 net loss from continuing operations hits USD 519 million as net sales rise 3% to USD 576 million Enovis reported Q4 FY2025 net sales of USD 576 million, up 3.0% on a reported basis, with a net loss from continuing operations of USD 519 million that included a non-cash goodwill impairment c
02-26 19:11
Enovis Q4 Adj. EPS $0.95 Beats $0.82 Estimate, Sales $575.758M Miss $583.848M Estimate
Enovis (NYSE:ENOV) reported quarterly earnings of $0.95 per share which beat the analyst consensus estimate of $0.82 by 15.57 percent. This is a 3.06 percent decrease over earnings of $0.98 per share from the same period
02-26 19:10
